TMCnet News
Kronos Bio Announces Participation in H.C. Wainwright 23rd Annual Global Investment ConferenceSAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13th at 7 a.m. ET. The fireside chat will be webcast live from the Investors & Media section of the company’s website at?www.kronosbio.com. A replay of the webcast will be archived and available for one month following the event. About Kronos Bio, Inc. Kronos Bio is based in San Mateo, Calif., and has a research facility in Cambridge, Mass. For more information, visit www.kronosbio.com or follow the company on LinkedIn. Investors: Media:
|